Koninklijke DSM NV buy melinda
Start price
18.05.16
/
50%
€52.14
Target price
04.11.19
€61.00
Performance (%)
111.64%
End price
04.11.19
€110.35
Summary
This prediction ended on 04.11.19 with a price of €110.35. With a performance of 111.64% the BUY prediction by melinda was a big success. Dividends of €6.67 are taken into consideration when calculating the performance. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Koninklijke DSM NV | - | - | - | - |
| iShares Core DAX® | -0.992% | -3.231% | 11.661% | 16.545% |
| iShares Nasdaq 100 | -0.225% | -3.339% | 36.491% | 43.334% |
| iShares Nikkei 225® | -0.736% | -7.859% | 18.597% | 4.253% |
| iShares S&P 500 | -0.509% | -2.979% | 26.341% | 40.911% |
According to melinda what are the pros and cons of Koninklijke DSM NV for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Koninklijke DSM NV diskutieren
Stier
Wir heben unsere Ergebnisprognose für DSM mit wenigen Prozent wegen einer (erwarteten) fortschreitende Erholung der Vitamin - E - Preise und die Expansion in den US - Lebensmittelmarkt mit dem Fokus auf die Lieferung an den Einzelhandel Private - Label. Wir behalten unser Kursziel von EUR 61 unserer Beratung basierend auf dem Wert der Summe der Teile (drei Joint Ventures , bevor sie verkauft werden).
Stopped prediction by melinda for Koninklijke DSM NV
Koninklijke DSM NV
Start price
Target price
Perf. (%)
€197.80
09.12.21
09.12.21
€210.00
09.12.22
09.12.22
-38.90%
10.12.22
10.12.22
Could be worthwhile Investment >10% per year
Koninklijke DSM NV
Start price
Target price
Perf. (%)
€126.85
06.07.20
06.07.20
€130.00
04.11.21
04.11.21
49.35%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year